Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction

NCT03359304 is registered in ClinicalTrials.gov with Ren tingting as lead sponsor.

NCT NCT03359304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03359304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction
Lead sponsor
Ren tingting
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2018
Completion date
March 1, 2028
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatoses